Divi’s Laboratories Q1 Results: The Hyderabad-based pharma giant posted a consolidated revenue of ₹2,410 crore from operations in the first quarter of FY26, reflecting a 13.8% increase from ₹2,118 crore in the corresponding quarter last year.
Originally published by The Economic Times https://economictimes.indiatimes.com/markets